Both in vitro and in vivo studies have demonstrated that the introduction of SENP3-EIF4A1 functions as a tumor suppressor, inhibiting the proliferation and migration of HCC cells and acting as a competitor of the miR-9-5p target [114]. Here, EIF4A1 is linked to hepatocellular carcinoma.